Elusys Therapeutics
Elusys Therapeutics Inc. PAC (A.k.a. Elusys American Biodefense PAC)
Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodElusys Therapeutics reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 1 outside firm. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Defense8/8
- Health Issues8/8
- Medical/Disease Research/Clinical Labs8/8
Bills named in the filings 12 bills, this period
- H.R. 2707 Protecting American Families and Servicemembers from Anthrax Act7 filings
- H.R. 3838 Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 Broad bill3 filings
- S. 2587 / H.R. 5304 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 Broad bill3 filings
- H.R. 9010 Making appropriations for the Legislative Branch for the fiscal year ending September 30, 2027, and for other purposes. Broad bill2 filings
- H.R. 9260 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 Broad bill2 filings
7 more, 4 named in only one filing · Show all 12
- H.R. 9495 Department of Defense Appropriations Act, 2027 Broad bill2 filings
- S. 2572 / H.R. 4016 Department of Defense Appropriations Act, 2026 Broad bill2 filings
- S. 4784 / H.R. 8800 National Defense Authorization Act for Fiscal Year 2027 Broad bill2 filings
- H.R. 4421, 118th Preparing for All Hazards and Pathogens Reauthorization Act1 filing
- S. 2333, 118th Pandemic and All-Hazards Preparedness and Response Act1 filing
- H.R. 2670, 118th National Defense Authorization Act for Fiscal Year 2024 Broad bill1 filing
- H.R. 2882, 118th Further Consolidated Appropriations Act, 2024 Broad bill1 filing
From the filings
“H.R. 2707, Protecting American Families and Servicemembers From Anthrax Act National Defense Authorization Act, 2026 Appropriations Legislation, 2026 Pandemic All Hazards and Preparedness Act Reauthorization”
“Advocacy for medical countermeasure funding and support.”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- DOD
- HHS
- NSC
- OSTP
- DHS
- Office of the Vice President of the United States
- DOS
The House and Senate appear in every quarter; agencies in all 8 quarters.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Elusys Therapeutics, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 3 sitting members of Congress in 2025–26.
See every candidate and member Elusys Therapeutics gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in